🔗 Share this article

Texas Attorney General Paxton is taking legal action against the producers of acetaminophen, asserting the companies concealed safety concerns that the drug presented to pediatric neurological development.

The lawsuit comes four weeks after President Donald Trump advocated an unverified association between taking Tylenol - referred to as paracetamol - while pregnant and autism spectrum disorder in children.

Paxton is taking legal action against the pharmaceutical giant, which formerly manufactured the medication, the sole analgesic approved for women during pregnancy, and Kenvue, which currently produces it.

In a official comment, he stated they "deceived the public by gaining financially from suffering and marketing drugs ignoring the potential hazards."

The company states there is lacking scientific proof connecting Tylenol to autism.

"These corporations deceived for years, knowingly endangering countless individuals to boost earnings," the attorney general, a Republican, said.

The company stated officially that it was "seriously troubled by the perpetuation of misinformation on the reliability of paracetamol and the likely effects that could have on the health of women and children in America."

On its online platform, the company also said it had "regularly reviewed the applicable studies and there is lacking reliable evidence that shows a verified association between using acetaminophen and autism spectrum disorder."

Associations acting on behalf of medical professionals and healthcare providers concur.

The leading OB-GYN organization has stated paracetamol - the primary component in Tylenol - is a restricted selection for expectant mothers to manage discomfort and elevated temperature, which can pose serious health risks if left untreated.

"In more than two decades of investigation on the use of acetaminophen in pregnancy, no reliable research has definitively established that the consumption of acetaminophen in any trimester of pregnancy results in brain development issues in young ones," the organization commented.

The court filing references recent announcements from the previous government in asserting the medication is reportedly hazardous.

Last month, the former president caused concern from medical authorities when he told women during pregnancy to "resist strongly" not to consume acetaminophen when ill.

The US Food and Drug Administration then published an announcement that physicians should consider limiting the consumption of Tylenol, while also stating that "a proven link" between the drug and autism in young ones has not been established.

The Health Department head RFK Jr, who supervises the FDA, had vowed in April to conduct "comprehensive study program" that would establish the cause of autism spectrum disorder in a short period.

But experts warned that finding a unique factor of autism spectrum disorder - considered by experts to be the result of a complicated interplay of genetic and environmental factors - would not be simple.

Autism spectrum disorder is a category of permanent neurological difference and impairment that affects how persons encounter and interact with the surroundings, and is identified using physician assessments.

In his court filing, the attorney general - who supports Trump who is seeking federal office - alleges the manufacturer and Johnson & Johnson "deliberately disregarded and sought to suppress the evidence" around paracetamol and autism.

The case seeks to make the corporations "remove any promotional materials" that claims acetaminophen is reliable for expectant mothers.

The court case parallels the concerns of a group of guardians of minors with autism spectrum disorder and ADHD who sued the makers of acetaminophen in recently.

Judicial authorities rejected the lawsuit, saying research from the family's specialists was inconclusive.